Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. - Wikidata - wikimedia - TriplyDB

Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections.

Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections.

http://www.wikidata.org/entity/Q30977897

about

Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III - convergence toward clinical trials Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains Proteomics Research in Schizophrenia In Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric Disorders Innate and adaptive immunity in the development of depression: An update on current knowledge and technological advances A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates Insulin in the nervous system and the mind: Functions in metabolism, memory, and mood A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy Multidimensional mapping method using an arrayed sensing system for cross-reactivity screening Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder.Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders.The Application of Multiplex Biomarker Techniques for Improved Stratification and Treatment of Schizophrenia Patients.Application of Proteomic Techniques for Improved Stratification and Treatment of Schizophrenia Patients.Identification of subgroups of schizophrenia patients with changes in either immune or growth factor and hormonal pathways Plasma protein profiling reveals protein clusters related to BMI and insulin levels in middle-aged overweight subjects Model-based optimization approaches for precision medicine: A case study in presynaptic dopamine overactivity.Inflammatory molecular signature associated with infectious agents in psychosis.Overexpression of MMP-9 and its inhibitors in blood mononuclear cells after myocardial infarction--is it associated with depressive symptomatology?Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia Toll-like receptor 4: innate immune regulator of neuroimmune and neuroendocrine interactions in stress and major depressive disorder Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer.Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder.Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions.Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?Sex differences in psychiatric comorbidity and plasma biomarkers for cocaine addiction in abstinent cocaine-addicted subjects in outpatient settings.Plasma concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: relationship to psychiatric comorbidity Imaging of thalamocortical dysrhythmia in neuropsychiatry.Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia.Functional biomarkers of depression: diagnosis, treatment, and pathophysiology Altered activation of innate immunity associates with white matter volume and diffusion in first-episode psychosis.Proteomic and metabolomic profiling of a trait anxiety mouse model implicate affected pathways Co-expression network of neural-differentiation genes shows specific pattern in schizophrenia.Urinary metabonomics for diagnosis of depression in hepatitis B virus-infected patients.Neurotrophins role in depression neurobiology: a review of basic and clinical evidence.Monocyte and microglial activation in patients with mood-stabilized bipolar disorder.Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression.Plasma biomarkers of depressive symptoms in older adults.Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression.

P2860

Q24600527-6FD89C0A-44C4-4983-8C9E-DC709B5DAA09 Q24632901-58338E27-68EF-44C5-940E-D1318853C38C Q26766821-D8B0FC62-D83A-44FB-82A3-B58B8512A3CF Q26769948-4554514D-A7EE-4CCB-9CA0-A72EDCC8A529 Q26775316-4B73D9CC-2C67-4B74-A77F-AC5E25CC147D Q26786354-0F3E61DE-EAE8-4FF0-BFEC-92AA0235F110 Q28079442-B23A9C86-6959-4BF2-8712-87D21CB257C7 Q28480936-9FE5C01A-F756-49E3-8170-DF4D8A9A3CE6 Q28544674-9F485889-DBAE-4179-9D88-0B8685B7E889 Q30801268-3A78B17C-0A79-4F76-BB60-CF160FC0925C Q30823738-F860F546-B1C2-48CE-9440-F69D73996612 Q33451672-9D2B19A9-E3ED-4280-8BCD-1E46D3234D8A Q33453744-B7514C16-8DA6-4653-9B4D-B107D48710A1 Q33762512-5CA5E232-0325-4FDF-993E-1203F69DB1BE Q33784462-C4870C39-A0AF-46B9-8082-1A95ED3DBF22 Q33797632-178280F9-3251-46A0-9649-5BFED57AA171 Q34048637-DC15C6EA-C976-4C5A-9424-4C5C4F40CDED Q34083836-A999DE25-EBFE-4284-9B57-B6A95AFA8AA8 Q34113374-B8562B23-04ED-4D4E-B3A3-67C7A64F5D26 Q34265484-2A27CE6A-8940-476B-806D-B29BC8DC7396 Q34326478-DAAE0C58-C59C-4074-88F8-319A1421613C Q34374580-F8CF3F93-BCB1-4771-A5CE-C6296C79DC1E Q34484906-EF85B854-86F1-451A-9E5F-2E820110D19D Q34569403-5997D8BD-DBAE-4134-BA92-24C7B4C769A7 Q34621808-DA26C3E6-71D8-4B15-8098-0E2DE022FE4A Q34768858-C94FD16B-C9F1-4F64-8EB9-741E7A2D2C2F Q35087097-A9505951-E70C-44E2-920E-F0C90EE86F09 Q35143914-00E5421D-1BCD-4246-A99F-9AC8C2257B15 Q35144326-51FC9EBE-A5ED-4A12-898F-30F26ED668FE Q35162008-F18DE5B4-6F88-4A4F-9D07-CB1B3AE3AE5D Q35356872-C61550E6-0C1C-44B2-8C0A-F94E0B550309 Q35603078-A6FA672A-FD59-4526-8501-70D2A8D05359 Q35610645-ABD8B3EB-980A-40EF-8153-A4B361650A45 Q35633578-B9F8C79B-A892-4279-8A9F-1106D6F443ED Q35645024-220F6908-884B-4D42-B709-18ACF11D12FE Q35687024-B0349ACA-D9BB-4127-BF1D-CED1B0476ADB Q35772084-42C1E72C-CDA0-4433-A26D-67887D7E7F9C Q35828096-AD4F4960-D894-4257-B0E8-69ADD1745EFF Q35844316-C70E20A2-BC7B-42D1-AF6F-21135CDCEA89 Q35913907-379E4821-0D9F-48A5-8731-F6F1A06DE8CB

P2860

Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections.

http://www.wikidata.org/entity/Q30977897

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Plasma protein biomarkers for ...... g of case-control collections.

@ast

Plasma protein biomarkers for ...... g of case-control collections.

@en

type

label

Plasma protein biomarkers for ...... g of case-control collections.

@ast

Plasma protein biomarkers for ...... g of case-control collections.

@en

prefLabel

Plasma protein biomarkers for ...... g of case-control collections.

@ast

Plasma protein biomarkers for ...... g of case-control collections.

@en

P1433

Q30977897-70C27268-0619-442A-9C23-29DCF556EA39

P1476

Q30977897-844DD426-29E4-4098-8407-717D954FF7B7

P2093

Q30977897-42FD9CDA-33B4-43E4-BC52-D255F06A68AB

Q30977897-4E24AB28-F572-4644-AC58-E48C64D143F4

Q30977897-5D3E8EEB-A081-4B3A-83A5-45424716822E

Q30977897-898B13FE-B0BC-46ED-9517-B4313F50F9EC

Q30977897-8AA5FDDB-9993-491C-9C27-50C4308FC1A0

Q30977897-8CCDF78D-8276-47AF-95F8-2EF882D58847

Q30977897-AEEA8B0E-C0BB-4A2A-AD0B-443D9C28A55D

Q30977897-E412FD39-1341-4026-A47F-47793D01DEC6

Q30977897-EBA52BCC-076A-49FD-9147-36ADB20FABCE

P2860

Q30977897-13289849-EE22-403D-B866-355DB3D9F0DB

Q30977897-1AA3806A-6EC6-4862-909F-CD1362900ACB

Q30977897-1F245766-021F-40C7-88EE-3BED26E55E00

Q30977897-291965E3-DA16-4AB8-8016-241A82B54548

Q30977897-2D547FD9-FDCE-4AB3-A9F5-E708332331A7

Q30977897-3C4AFA1E-F437-4403-A22D-26C3990B4577

Q30977897-41B0578F-D7F0-4A39-AE88-BAEB6B438CCF

Q30977897-422FEC71-6F68-43E1-B05A-DFB7FCFD5D68

Q30977897-43C16AF2-9C59-494F-84E4-A7641ECFBB0C

Q30977897-5173AD35-F0EE-4E59-B064-CC2359163FB7

P304

Q30977897-30A67F78-09B5-4F50-8846-1A4D8A011C84

P31

Q30977897-F98EE397-F577-459E-B9DB-A21D5347B58F

P356

Q30977897-7F573825-4C3A-4FA4-A7F1-9332204D09A8

P407

Q30977897-C7D9CD2F-6B97-4F6F-9AD4-281ACF763044

P433

Q30977897-5107398F-4DF9-45E6-8EF2-A95BFC964D7B

P478

Q30977897-B57BCDBA-6C24-42D8-A5C5-7D341285B4D5

P50

Q30977897-086E3809-AFEA-49FB-BEAE-79DA673DCD85

Q30977897-39F7BC83-CA3A-461C-AB01-F418DFB18F32

Q30977897-3DB14E8E-AB03-4AE8-A769-ABBDA32D2F9B

Q30977897-69A22A4D-054C-4BA8-B2B7-DAD76CFA6F87

Q30977897-A8134D2D-731C-40CD-80A5-7050B65B5CF2

Q30977897-B78800AA-7318-433A-959C-F733AB861FBA

Q30977897-D497946B-5B73-4D8A-A3A6-83A102501398

P577

Q30977897-DC33F449-82D4-4E74-AD3B-75ABA42FF715

P5875

Q30977897-5EB24DDD-4CB2-4605-B72D-C7C567EEDD01

P698

Q30977897-157BEF1D-5DA2-4E81-882A-A5C4E75A853F

P921

Q30977897-268B63C1-0ECB-41AB-9C4F-F56C0C4A814E

Q30977897-C3CBEC5E-7B1C-4ED5-90C5-D4AC7ABFB98C

P932

Q30977897-D8FF1928-2FB4-4E6F-A6DD-2F4430E4D7F3

P356

JOURNAL.PONE.0009166

P1433

P1476

Plasma protein biomarkers for ...... g of case-control collections.

@en

P2093

Astrid McKeown

http://www.w3.org/2001/XMLSchema#string

Christoph W Turck

http://www.w3.org/2001/XMLSchema#string

Claire Brittain

http://www.w3.org/2001/XMLSchema#string

David R Willé

http://www.w3.org/2001/XMLSchema#string

Emilio Merlo-Pich

http://www.w3.org/2001/XMLSchema#string

Lefkos Middleton

http://www.w3.org/2001/XMLSchema#string

Pierandrea Muglia

http://www.w3.org/2001/XMLSchema#string

Robert C Alexander

http://www.w3.org/2001/XMLSchema#string

Sam Miller

http://www.w3.org/2001/XMLSchema#string

P2860

Cytokines sing the blues: inflammation and the pathogenesis of depression

Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications

In vivo roles for matrix metalloproteinase-9 in mature hippocampal synaptic physiology and plasticity

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory.

A genome-wide investigation of SNPs and CNVs in schizophrenia.

Multiplexed microbead immunoassays by flow cytometry for molecular profiling: Basic concepts and proteomics applications.

Cytokine dysregulation, inflammation and well-being.

Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets.

The comorbidity of diabetes mellitus and depression

P304

e9166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0009166

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Florian Holsboer

Edward T. Bullmore

Inga Prokopenko

Enrico Domenici

P577

2010-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41453596

http://www.w3.org/2001/XMLSchema#string

P698

20161799

http://www.w3.org/2001/XMLSchema#string

P921

P932

2820097

http://www.w3.org/2001/XMLSchema#string